Scientific Publications

Legend Biotech sponsors research with academic institutions to evaluate our agents. The manuscripts from this research are presented below.

Year :

Outcomes in patients with multiple myeloma receiving salvage treatment after BCMA-specific CAR-T therapy: A retrospective analysis of LEGEND-2

Rui Liu, Rui Yang, Xuezhu Xu, Wanhong Zhao, Fangxia Wang, Wanggang Zhang, Bo Lei, Ruoyu Yang, Yiwen Wang, Aili He, Jianli Wang

Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion Study

Maria-Victoria Mateos, Katja Weisel, Joris Diels, Alberto Arribas, Maria Tamayo, Jordan M. Schecter, Tito Roccia, Imène Haddad, Lida Pacaud, Philippe Moreau

Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver Perspective

Doris K Hansen, Todd Bixby, Karen Fixler, Lisa Shea, Christine Brittle, Kimberly Brunisholz, Yi-Hsuan Liu, Jinhai Stephen Huo

Nursing Care Throughout the Chimeric Antigen Receptor T-Cell Therapy Process for Multiple Myeloma

Mary Steinbach, Laura J Zitella, Erika Florendo, Erin Lee, Carrie Riccobono, Heather DiFilippo, Elizabeth Aronson

Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study

M Htut, B Dhakal, AD Cohen, T Martin, JG Berdeja, SZ Usmani, M Agha, CC. Jackson, D Madduri, W Deraedt, E Zudaire, T Yeh, X Xu, L Pacaud, M Akram, S Jagannath